SYNDAX PHARMACEUTICALS INC
(87164F105)
ファンドの報告 SYNDAX PHARMACEUTICALS INC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| MPM Asset Management LLC | 2,168,691 | $20,191k | Jun 30, 2019 | Aug 14, 2019 | |
| 683 Capital Management LLC | 1,615,955 | $15,045k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 212,000 | $1,974k | Jun 30, 2019 | Aug 14, 2019 | |
| Sofinnova Ventures Inc | 103,679 | $965k | Jun 30, 2019 | Aug 13, 2019 | |
| Campbell & Company Investment Adviser LLC | 39,372 | $367k | Jun 30, 2019 | Jul 10, 2019 | |
| Acadian Asset Management LLC | 20,505 | $191k | Jun 30, 2019 | Aug 8, 2019 |